img

Global Cholera Vaccine (Oral Route) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cholera Vaccine (Oral Route) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Cholera Vaccine (Oral Route) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cholera Vaccine (Oral Route) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Research & Academic Laboratories are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cholera Vaccine (Oral Route) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cholera Vaccine (Oral Route) key manufacturers include PaxVax, Sanofi, Valneva and EuBiologics, etc. PaxVax, Sanofi, Valneva are top 3 players and held % sales share in total in 2022.
Cholera Vaccine (Oral Route) can be divided into Shanchol, Dukoral, Vaxchora and Others, etc. Shanchol is the mainstream product in the market, accounting for % sales share globally in 2022.
Cholera Vaccine (Oral Route) is widely used in various fields, such as Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others, etc. Hospital provides greatest supports to the Cholera Vaccine (Oral Route) industry development. In 2022, global % sales of Cholera Vaccine (Oral Route) went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cholera Vaccine (Oral Route) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


PaxVax
Sanofi
Valneva
EuBiologics
Segment by Type
Shanchol
Dukoral
Vaxchora
Others

Segment by Application


Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Cholera Vaccine (Oral Route) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cholera Vaccine (Oral Route), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cholera Vaccine (Oral Route) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cholera Vaccine (Oral Route) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cholera Vaccine (Oral Route) introduction, etc. Cholera Vaccine (Oral Route) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cholera Vaccine (Oral Route) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Cholera Vaccine (Oral Route) Market Overview
1.1 Cholera Vaccine (Oral Route) Product Overview
1.2 Cholera Vaccine (Oral Route) Market Segment by Type
1.2.1 Shanchol
1.2.2 Dukoral
1.2.3 Vaxchora
1.2.4 Others
1.3 Global Cholera Vaccine (Oral Route) Market Size by Type
1.3.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Type (2018-2034)
1.3.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Type (2018-2024)
1.3.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2024)
1.4.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2024)
2 Global Cholera Vaccine (Oral Route) Market Competition by Company
2.1 Global Top Players by Cholera Vaccine (Oral Route) Sales (2018-2024)
2.2 Global Top Players by Cholera Vaccine (Oral Route) Revenue (2018-2024)
2.3 Global Top Players by Cholera Vaccine (Oral Route) Price (2018-2024)
2.4 Global Top Manufacturers Cholera Vaccine (Oral Route) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cholera Vaccine (Oral Route) Market Competitive Situation and Trends
2.5.1 Cholera Vaccine (Oral Route) Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cholera Vaccine (Oral Route) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
2.7 Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
2.8 Key Manufacturers Cholera Vaccine (Oral Route) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cholera Vaccine (Oral Route) Status and Outlook by Region
3.1 Global Cholera Vaccine (Oral Route) Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Cholera Vaccine (Oral Route) Historic Market Size by Region
3.2.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2018-2024)
3.2.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2018-2024)
3.2.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Region
3.3.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2024-2034)
3.3.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2024-2034)
3.3.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cholera Vaccine (Oral Route) by Application
4.1 Cholera Vaccine (Oral Route) Market Segment by Application
4.1.1 Hospital
4.1.2 Research & Academic Laboratories
4.1.3 Pharmaceutical & Biotechnology Companies
4.1.4 Others
4.2 Global Cholera Vaccine (Oral Route) Market Size by Application
4.2.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Application (2018-2034)
4.2.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Application (2018-2024)
4.2.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2024)
4.3.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2024)
5 North America Cholera Vaccine (Oral Route) by Country
5.1 North America Cholera Vaccine (Oral Route) Historic Market Size by Country
5.1.1 North America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2024)
5.1.3 North America Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2024)
5.2 North America Cholera Vaccine (Oral Route) Forecasted Market Size by Country
5.2.1 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2034)
5.2.2 North America Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2034)
6 Europe Cholera Vaccine (Oral Route) by Country
6.1 Europe Cholera Vaccine (Oral Route) Historic Market Size by Country
6.1.1 Europe Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2024)
6.1.3 Europe Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2024)
6.2 Europe Cholera Vaccine (Oral Route) Forecasted Market Size by Country
6.2.1 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2034)
6.2.2 Europe Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2034)
7 Asia-Pacific Cholera Vaccine (Oral Route) by Region
7.1 Asia-Pacific Cholera Vaccine (Oral Route) Historic Market Size by Region
7.1.1 Asia-Pacific Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Cholera Vaccine (Oral Route) Forecasted Market Size by Region
7.2.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Value by Region (2024-2034)
8 Latin America Cholera Vaccine (Oral Route) by Country
8.1 Latin America Cholera Vaccine (Oral Route) Historic Market Size by Country
8.1.1 Latin America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2024)
8.1.3 Latin America Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2024)
8.2 Latin America Cholera Vaccine (Oral Route) Forecasted Market Size by Country
8.2.1 Latin America Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2034)
9 Middle East and Africa Cholera Vaccine (Oral Route) by Country
9.1 Middle East and Africa Cholera Vaccine (Oral Route) Historic Market Size by Country
9.1.1 Middle East and Africa Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Cholera Vaccine (Oral Route) Forecasted Market Size by Country
9.2.1 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 PaxVax
10.1.1 PaxVax Company Information
10.1.2 PaxVax Introduction and Business Overview
10.1.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2024)
10.1.4 PaxVax Cholera Vaccine (Oral Route) Products Offered
10.1.5 PaxVax Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Cholera Vaccine (Oral Route) Products Offered
10.2.5 Sanofi Recent Development
10.3 Valneva
10.3.1 Valneva Company Information
10.3.2 Valneva Introduction and Business Overview
10.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Valneva Cholera Vaccine (Oral Route) Products Offered
10.3.5 Valneva Recent Development
10.4 EuBiologics
10.4.1 EuBiologics Company Information
10.4.2 EuBiologics Introduction and Business Overview
10.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2024)
10.4.4 EuBiologics Cholera Vaccine (Oral Route) Products Offered
10.4.5 EuBiologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cholera Vaccine (Oral Route) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cholera Vaccine (Oral Route) Industrial Chain Analysis
11.4 Cholera Vaccine (Oral Route) Market Dynamics
11.4.1 Cholera Vaccine (Oral Route) Industry Trends
11.4.2 Cholera Vaccine (Oral Route) Market Drivers
11.4.3 Cholera Vaccine (Oral Route) Market Challenges
11.4.4 Cholera Vaccine (Oral Route) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cholera Vaccine (Oral Route) Distributors
12.3 Cholera Vaccine (Oral Route) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Shanchol
Table 2. Major Company of Dukoral
Table 3. Major Company of Vaxchora
Table 4. Major Company of Others
Table 5. Global Cholera Vaccine (Oral Route) Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 7. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (US& Million)
Table 9. Global Cholera Vaccine (Oral Route) Market Share in Value by Type (2018-2024)
Table 10. Global Cholera Vaccine (Oral Route) Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2034) & (K Units)
Table 12. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Type (2024-2034)
Table 15. Global Cholera Vaccine (Oral Route) Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 17. North America Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2024)
Table 19. Europe Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2024)
Table 23. Latin America Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Cholera Vaccine (Oral Route) Sales by Company (2018-2024) & (K Units)
Table 27. Global Cholera Vaccine (Oral Route) Sales Share by Company (2018-2024)
Table 28. Global Cholera Vaccine (Oral Route) Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Cholera Vaccine (Oral Route) Revenue Share by Company (2018-2024)
Table 30. Global Market Cholera Vaccine (Oral Route) Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Cholera Vaccine (Oral Route) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Cholera Vaccine (Oral Route) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
Table 34. Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
Table 35. Key Manufacturers Cholera Vaccine (Oral Route) Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Cholera Vaccine (Oral Route) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2024) & (K Units)
Table 39. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2018-2024)
Table 42. Global Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2034) & (K Units)
Table 44. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2024-2034)
Table 47. Global Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Cholera Vaccine (Oral Route) Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 50. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2018-2024)
Table 53. Global Cholera Vaccine (Oral Route) Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2034) & (K Units)
Table 55. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2024-2034)
Table 58. Global Cholera Vaccine (Oral Route) Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Cholera Vaccine (Oral Route) Sales by Application (2018-2024) (K Units)
Table 60. North America Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2024) (K Units)
Table 62. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2024) (K Units)
Table 66. Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 70. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2024)
Table 73. North America Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 74. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 78. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 82. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 109. PaxVax Company Information
Table 110. PaxVax Introduction and Business Overview
Table 111. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. PaxVax Cholera Vaccine (Oral Route) Product
Table 113. PaxVax Recent Development
Table 114. Sanofi Company Information
Table 115. Sanofi Introduction and Business Overview
Table 116. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sanofi Cholera Vaccine (Oral Route) Product
Table 118. Sanofi Recent Development
Table 119. Valneva Company Information
Table 120. Valneva Introduction and Business Overview
Table 121. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Valneva Cholera Vaccine (Oral Route) Product
Table 123. Valneva Recent Development
Table 124. EuBiologics Company Information
Table 125. EuBiologics Introduction and Business Overview
Table 126. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. EuBiologics Cholera Vaccine (Oral Route) Product
Table 128. EuBiologics Recent Development
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Cholera Vaccine (Oral Route) Market Trends
Table 132. Cholera Vaccine (Oral Route) Market Drivers
Table 133. Cholera Vaccine (Oral Route) Market Challenges
Table 134. Cholera Vaccine (Oral Route) Market Restraints
Table 135. Cholera Vaccine (Oral Route) Distributors List
Table 136. Cholera Vaccine (Oral Route) Downstream Customers
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholera Vaccine (Oral Route) Product Picture
Figure 2. Global Cholera Vaccine (Oral Route) Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cholera Vaccine (Oral Route) Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Cholera Vaccine (Oral Route) Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Shanchol
Figure 6. Global Shanchol Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Dukoral
Figure 8. Global Dukoral Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Vaxchora
Figure 10. Global Vaxchora Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Cholera Vaccine (Oral Route) Sales Market Share by Type in 2022 & 2034
Figure 15. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 16. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 17. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 18. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 21. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccine (Oral Route) Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccine (Oral Route) Revenue in 2022
Figure 27. Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Research & Academic Laboratories
Figure 31. Global Research & Academic Laboratories Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 33. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Cholera Vaccine (Oral Route) Sales Market Share by Application in 2022 & 2034
Figure 38. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 39. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 40. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 41. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 44. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Cholera Vaccine (Oral Route) Manufacturing Cost Structure
Figure 49. Cholera Vaccine (Oral Route) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries